Reports for BAXTER CORPORATION
Formerly known as PHARMASCIENCE INC
Company Name
BAXTER CORPORATION
Shortage reports
Actual shortage:
4 (2%)
Anticipated shortage:
3 (1%)
Avoided shortage:
3 (1%)
Resolved:
217 (96%)
227
Discontinuation Reports
To be discontinued:
4 (13%)
Discontinued:
26 (87%)
Reversed:
0 (0%)
30
18 (7%)
9 (82%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2024-02-27 | 2024-03-19 | 220718 |
| MYXREDLIN | 1UNIT | SOLUTION | Resolved | 2024-10-24 | 2024-11-12 | 241104 |
| NITROGLYCERIN IN 5% DEXTROSE INJ.-200MCG/ML | 5G 20MG | SOLUTION | Resolved | 2019-03-01 | 2019-03-19 | 77245 |
| NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML | 5G 40MG | SOLUTION | Resolved | 2019-05-01 | 2019-05-22 | 82898 |
| NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION | 0.032MG | SOLUTION | Resolved | 2024-07-17 | 2024-08-30 | 233218 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Resolved | 2018-05-23 | 2018-06-22 | 50095 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Resolved | 2018-11-22 | 2019-02-27 | 67436 |
| OLIMEL 4.4% E | 2.64G 0.74G 1.50G 6.41G 8G 154G 3.67G 0.81G 0.52G 2.24G 32G 2.21G 3.07G 2.21G 0.11G 2.64G 4.34G 2.83G 1.28G 2.21G 3.07G 3.07G 2.21G 3.48G 1.75G | EMULSION | Resolved | 2017-07-10 | 2017-08-16 | 15024 |
| PLASMA-LYTE A INJECTION | 368MG 30MG 37MG 526MG 502MG | SOLUTION | Resolved | 2019-02-15 | 2019-03-19 | 76031 |
| PLASMA-LYTE A INJECTION | 526MG 368MG 502MG 37MG 30MG | SOLUTION | Resolved | 2020-08-17 | 2020-09-01 | 122375 |
| PLASMA-LYTE A INJECTION | 526MG 368MG 502MG 37MG 30MG | SOLUTION | Resolved | 2020-08-17 | 2020-08-18 | 122377 |
| PMS-PROPOFOL | 10MG | EMULSION | Resolved | 2018-03-19 | 2020-06-10 | 43360 |
| PMS-PROPOFOL | 10MG | EMULSION | Resolved | 2018-03-23 | 2020-06-10 | 43857 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 300MG 900MG | SOLUTION | Resolved | 2017-05-04 | 2017-09-26 | 9057 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | SOLUTION | Resolved | 2022-02-25 | 2022-03-26 | 155672 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | SOLUTION | Resolved | 2022-08-31 | 2022-11-02 | 168276 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | SOLUTION | Actual shortage | 2025-01-08 | 2025-05-02 | 247098 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-01-12 | 2018-02-06 | 35770 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-08-13 | 2018-08-29 | 58038 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-12-14 | 2018-12-20 | 69676 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP | 150MG 5G | SOLUTION | To be discontinued | 2025-09-03 | 2025-09-03 | 257296 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | 150MG 450MG 5G | SOLUTION | To be discontinued | 2025-10-14 | 2025-10-14 | 257560 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | 150MG 450MG 5G | SOLUTION | To be discontinued | 2025-10-14 | 2025-10-14 | 257563 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120955 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120952 |
| 1.6% SODIUM CHLORDIE PROCESSING SOLUTION | 1.6G | SOLUTION SOLUTION | Discontinued | 2022-12-13 | 2023-01-01 | 178273 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120958 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120961 |
| ACID CONCENTRATE 2120 | 67.5G 10.8G 1.61G 7.49G 10.06G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7237 |
| ACID CONCENTRATE 2125 | 89.99G 8.11G 3.21G 7.74G 3.35G 268.24G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7240 |
| ACID CONCENTRATE 2139 | 89.99G 8.11G 3.21G 7.74G 10.06G 268.24G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7243 |
| ACID CONCENTRATE 2152 | 89.99G 8.11G 3.21G 6.24G 6.71G 268.24G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7246 |
| ACID CONCENTRATE 2163 | 90G 10.8G 2.14G 6.24G 10.06G 275G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7249 |
| ACID CONCENTRATE 2171 | 112.53G 5.4G 3.21G 2.5G 8.39G 262.98G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7252 |
| ACID CONCENTRATE 2198 | 10.8G 1.61G 7.49G 10.1G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7255 |
| ACID CONCENTRATE D12292 | 10.8G 1.61G 6.24G 3.35G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7261 |
| ACID CONCENTRATE D12304 | 90G 10.8G 1.61G 7.48G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7264 |
| ACID CONCENTRATE D12306 | 45G 10.8G 1.61G 7.49G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7267 |
| CIPROFLOXACIN INJECTION | 2MG | SOLUTION | Discontinued | 2020-07-21 | 2020-08-17 | 120710 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 300MG | SOLUTION | Discontinued | 2023-02-06 | 2023-04-02 | 183710 |